Effects of the Single Administration of the Anticholonergics, Trospium Chloride, on the Patients with Nocturia.

J. Wen, D. Kang, Sung-Hyup Choi, K. Min
{"title":"Effects of the Single Administration of the Anticholonergics, Trospium Chloride, on the Patients with Nocturia.","authors":"J. Wen, D. Kang, Sung-Hyup Choi, K. Min","doi":"10.5213/JKCS.2005.9.2.75","DOIUrl":null,"url":null,"abstract":"Purpose: The aim of this study was to evaluate the effects of the single administration of the anticholonergics, trospium chloride, in the nocturic patients without bladder outlet obstruction for mid-term. Materials and Methods: We included the 22 male and 102 female patients with nocturia over 3 times and without bladder outlet obstruction. Exclusion criteria was under 15 ml/sec in maximal flow rate, over 30 ml in post-void residual urine, nocturnal polyuria and medication affecting lower urinary tract symptoms including alpha-blockers, sedatives, muscle relaxants. Based on voiding diary for 3 days, frequency of the nocturia, daytime frequency and frequency of the urgency and urge incontinence were measured at pretreatment, post-treatment 1st month, 3rd month and 6th month. Additionally maximal flow rate and post-void residual urine were also recorded at the same periods. Anticholinergics was administered in flexible dose. Results: In frequency of nocturia, single administration of the anticholonergics improved significantly at post-treatment 1st, 3rd and 6th month compared to pre-treatment level. The more severe the frequency of the nocturia was, the more it was improved by medication but there is no significant difference. Daytime frequency is significantly improved 3 month and 6 month after medication. In urgency and urge incontinence, the significant improvement was also observed at post-treatment 3rd month and 6th month. The significant differences between pre-treatment and post-treatment were not demonstrated in maximal flow rate and post-void residual urine. Dry mouth was the most common side effect but mild and tolerable. Conclusion: The single administration of the trospium chloride demonstrated a clinically significant improvement in nocturia as well as symptoms of the overactive bladder and did not affect negatively on bladder contractility. (J. Korean Continence Society 2005;9:75-81)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"527 24","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2005-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Korean Continence Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5213/JKCS.2005.9.2.75","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The aim of this study was to evaluate the effects of the single administration of the anticholonergics, trospium chloride, in the nocturic patients without bladder outlet obstruction for mid-term. Materials and Methods: We included the 22 male and 102 female patients with nocturia over 3 times and without bladder outlet obstruction. Exclusion criteria was under 15 ml/sec in maximal flow rate, over 30 ml in post-void residual urine, nocturnal polyuria and medication affecting lower urinary tract symptoms including alpha-blockers, sedatives, muscle relaxants. Based on voiding diary for 3 days, frequency of the nocturia, daytime frequency and frequency of the urgency and urge incontinence were measured at pretreatment, post-treatment 1st month, 3rd month and 6th month. Additionally maximal flow rate and post-void residual urine were also recorded at the same periods. Anticholinergics was administered in flexible dose. Results: In frequency of nocturia, single administration of the anticholonergics improved significantly at post-treatment 1st, 3rd and 6th month compared to pre-treatment level. The more severe the frequency of the nocturia was, the more it was improved by medication but there is no significant difference. Daytime frequency is significantly improved 3 month and 6 month after medication. In urgency and urge incontinence, the significant improvement was also observed at post-treatment 3rd month and 6th month. The significant differences between pre-treatment and post-treatment were not demonstrated in maximal flow rate and post-void residual urine. Dry mouth was the most common side effect but mild and tolerable. Conclusion: The single administration of the trospium chloride demonstrated a clinically significant improvement in nocturia as well as symptoms of the overactive bladder and did not affect negatively on bladder contractility. (J. Korean Continence Society 2005;9:75-81)
抗胆碱能药物氯曲铵对夜尿症患者的影响。
目的:评价抗胆碱类药物氯曲曲铵对无膀胱出口梗阻的夜尿症中期患者的治疗效果。材料与方法:选取夜尿3次以上且无膀胱出口梗阻的患者,男22例,女102例。排除标准为最大尿流量小于15 ml/秒,空后残余尿大于30 ml,夜间多尿,以及影响下尿路症状的药物,包括α -受体阻滞剂、镇静剂、肌肉松弛剂。根据3 d排尿日记,分别于治疗前、治疗后第1个月、第3个月、第6个月测量夜尿次数、日间次数、尿急和尿急失禁次数。此外,在同一时期也记录了最大流量和空后残余尿。抗胆碱能药以灵活剂量给药。结果:在夜尿频率方面,单药抗胆能药物治疗后1、3、6个月较治疗前显著改善。夜尿愈严重,药物愈能改善夜尿,但无显著性差异。服药后3个月和6个月,日间频率明显改善。在急迫性和急迫性尿失禁方面,治疗后第3个月和第6个月也观察到显著改善。在最大流量和空后残余尿方面,治疗前后没有显著差异。口干是最常见的副作用,但温和且可忍受。结论:单次给药对夜尿症及膀胱过度活动症状有显著改善,且对膀胱收缩性无不良影响。(大韩自制学会2005;9:75-81)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信